Human Design Medical, LLC is a company.
Key people at Human Design Medical, LLC.
Human Design Medical, LLC was founded by Cainon Coates (Co-Founder & Operating Partner).
Key people at Human Design Medical, LLC.
Human Design Medical, LLC was founded by Cainon Coates (Co-Founder & Operating Partner).
Human Design Medical, LLC (HDM) is a medical equipment manufacturer specializing in compact, portable Continuous Positive Airway Pressure (CPAP) devices for sleep apnea patients.[3][2][6] Headquartered in Newton, Massachusetts, the company produces innovative products like the Z1 and Z2 CPAP machines, which are smartphone-sized yet deliver full therapy, including accessories such as PowerShell batteries for travel use.[2][4][6] These devices serve individuals with respiratory issues, particularly frequent travelers needing reliable sleep therapy without access to outlets, addressing portability challenges in traditional bulky CPAP systems.[3][6][7] With reported revenue around $1 million, HDM focuses on user-centric design as an affiliate of Breas Medical AB and a portfolio company of PBM Capital.[2][7]
Human Design Medical emerged from acquiring assets including the iSleep20i technology from AeioMed, Inc., which it ported into its flagship Z1 CPAP system without software changes, as cleared by FDA 510(k) in 2014.[5] Based initially in Boston and later Newton, MA, the company advanced this foundation by launching the Z1 Auto CPAP in December 2014, introducing auto-adjusting pressure monitoring thousands of times nightly for personalized therapy, paired with the Nitelog app for sleep data syncing.[5][7] Key figures include Maureen O’Connell as a regulatory contact and Steve Moore as Senior VP of Sales and Marketing, driving announcements and pre-orders via www.hdmusa.com.[5][7] Early FDA validations against predicates like Breas Medical's iSleep20i highlighted pivotal bench testing for pressure accuracy and stability.[5]
HDM rides the trend toward miniaturized, patient-centric medical devices in the $5B+ sleep apnea market, where portability addresses non-compliance from cumbersome equipment.[3][6][7] Timing aligns with rising telehealth and mobile health post-2014 launches, amplified by app integration amid smartphone ubiquity.[7] Favorable forces include aging populations with sleep disorders and demand for travel-friendly tech, positioning HDM to influence portable respiratory care as a PBM Capital portfolio player affiliated with global Breas Medical.[2][7] It pushes ecosystem shifts toward lifestyle-integrated therapy, reducing barriers for underserved travelers and frequent flyers.[6]
HDM's focus on compact, smart CPAPs positions it for growth in personalized sleep tech, potentially expanding via FDA-cleared iterations or accessories amid rising OSA awareness. Trends like AI-driven therapy and battery advancements will shape its path, with app ecosystems enabling data-driven expansions. Its influence may evolve through partnerships or acquisitions, solidifying portable CPAP leadership—echoing its origin in acquired tech turned user-friendly innovation.[5][7]
